Drug Discovery World

OCTOBER 16, 2023

The campus is home to GSK, the Cell and Gene Therapy Manufacturing Catapult, LifeArc and Cytiva, alongside a growing cluster of start-up companies which together have raised £2.9 Next, Saleko highligts how Northumberland and the North East of the UK are recognised for pharmaceutical manufacturing prowess. billion in funding.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Predictive Oncology

FEBRUARY 7, 2023

With its technology, the company wants to change the way that biopharma companies plan clinical trials and develop oncology drugs. This is all about getting the right drugs to the right patients at the right time as soon as possible to personalize the treatment of their therapies, primarily in oncology,” said Vennare.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Drug Target Review

OCTOBER 1, 2024

Following clinical practice, I transitioned to the world of pharmaceutical companies which also had its challenges as I had to learn everything from scratch and use my experience and knowledge differently. Moreover, increasing treatment complexity will require more sophisticated scientific exchange.

Doctors 64

Doctors Therapies Science Pharma Companies 64

Eye on FDA

JANUARY 9, 2022

As noted in the past, there are two primary means for understanding the agency’s latest thinking with respect to promotional communications from pharmaceutical companies – the content and pattern of enforcement and the issuance of guidance documents to shed light on the parameters that exist. Why This is a Fail.

FDA 64

FDA Pharma Companies Pharmaceutical Companies Production 64

H1 Blog

MARCH 27, 2023

As the primary interface between healthcare providers (HCPs) and pharmaceutical companies, medical science liaisons (MSLs) have a unique opportunity to engage with HCPs in clinical discussions and bridge care gaps by providing crucial insights into evidence-based medicine.

Science 52

Science Pharma Companies Pharmaceutical Companies Treatment 52

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. All study subjects will receive the same Ampligen treatments. I believe the data to date suggests that early treatment will lead to better levels of efficacy.”. development pipeline for ME/CFS. See: PLOS ONE ). AIM CEO Thomas K.

Clinical Trials 52

Clinical Trials Trials Virus International 52

Advarra

JULY 19, 2022

Q: If an emergency use authorization (EUA) is granted, once there is an approved treatment, does that mean that the EUA is no longer valid? The sponsor is the pharmaceutical company conducting the trial. A: Working in a pharmaceutical company is the best way to learn this. A: Yes, the EUA is just temporary.

Packaging 52

Packaging FDA Regulations Trials 52

Drug Discovery World

MAY 7, 2024

Add to this that the rise of AMR can bring about what the report calls a return to the ‘dark age of medicine’ where surgeries, cancer treatments, even childbirths, become staggeringly more dangerous when there is a lack of effective antibiotics, and it’s easy to understand why there’s such reason for concern.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

DrugBank

JUNE 27, 2024

Currently, about one-third of recent drug approvals and 25% of the pharmaceutical industry's annual revenue is coming from repurposed drugs.This trend is being championed industry-wide, by public organizations and nonprofits, with numerous small companies diving in and academic publications on the subject showing great popularity.

Drugs 71

Drugs Pharma Companies Computational Chemistry Clinical Trials 71

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

JANUARY 5, 2023

There is a real danger for companies simply reacting to the latest EMA mandates, such as the specifics of how data will look under the EU’s eventual implementation of Identification of Medicinal Products (IDMP), and the perceived ‘watering down’ of data-driven process requirements via the shift to Digital Application Dataset Integration (DADI).

Pharma Companies 130

Pharma Companies International Compliance Production 130

Alta Sciences

MARCH 27, 2024

Eryn has a wealth of expertise in diverse therapeutic areas and, after her experiences with battling cancer, a commitment to advancing the pharmaceutical industry by merging conventional and alternative treatments into one model. Get to know Eryn with this Q&A: What motivated you to pursue a doctorate degree?

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

The Open Targets Blog

OCTOBER 24, 2023

OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs. Although pharma companies can be competitive, this kind of tool will not generate any IP, and it saved us so much work that we knew it could be of real benefit to the community.

Bioinformatics 64

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 64

The Connected Lab

APRIL 8, 2020

For patients suffering from an illness with no approved treatment, the wait can be unnerving. To this day, more than 400 million people suffer from rare diseases and 95% of rare diseases lack an FDA approved treatment 3. The cost to develop a new prescription medicine that gains market approval has gone up 145% to $2.6

Pharma Companies 52

Pharma Companies Laboratories FDA Approval Drugs 52

The Pharma Data

NOVEMBER 11, 2020

TOKYO & AUSTIN, Texas–( BUSINESS WIRE )– Taiho Pharmaceutical Co., There currently are no approved drug treatment options for this condition. We are honored to partner with Taiho, a Japanese pharmaceutical company with a commitment to the respiratory field, for the development and commercialization of LTI-01 in Japan.

Licensing 40

Licensing Licensing Treatment Pharma Companies 40

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

Drug Target Review

APRIL 19, 2024

Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. We also have collaborations with pharmaceutical companies where we leverage the best of our unique platform and pharma expertise on the target.

Molecular Biology 111

Molecular Biology Pharmaceuticals Small Molecule Research 111

Drug Discovery World

NOVEMBER 15, 2022

If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . The longer the DNA gets, the longer it will take for labs to receive it,” notes Dr Daniels. “If

DNA 246

DNA Engineering Drugs Vaccine 246

Drug Target Review

MAY 23, 2023

Therapies developed in recent decades have transformed the treatment of IBD, making hospitalisation and surgery less common. However, many patients respond poorly to corticosteroid treatment, or their immune system responds unfavourably to biological therapies, such as the development of autoimmune diseases.

Drugs 75

Drugs Small Molecule Production Pharma Companies 75

Drug Discovery World

AUGUST 16, 2022

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. used in patient intake forms can influence clinical decisions or treatment protocols. As it relates to clinical support, cultural labels (race, ethnicity, etc.)

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 118

Therapies Virus DNA Clinical Trials 118

Drug Discovery World

SEPTEMBER 7, 2022

The drug discovery and development process is costly and arduous, offering no certainty of success which often rests on whether a company has chosen the correct drug molecule and target. The pharmaceutical industry is built on data. The challenge of data .

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor. adults age 65 and older.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Pharmaceutical Companies 52

The Pharma Data

DECEMBER 30, 2020

It also calls for ending the tax deductions that pharmaceutical companies can take for the amount of money it spends on advertising its medications. Four big companies are cited as possible tasty takeover targets for 2021. They are: • BioMarin Pharmaceutical. The company has a market cap of $15.4

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug & Device Law

APRIL 7, 2023

The case is Vanda Pharmaceuticals, Inc. 27, 2023), and the plaintiff was a pharmaceutical company that wanted to know what the FDA really thought of its drug. The company lodged a request under the Freedom of Information Act (“FOIA”), which the FDA refused. 22-cv-938, 2023 U.S. LEXIS 51853 (D.D.C. Here is what happened.

FDA 64

FDA Government Pharma Companies Regulations 64